LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global thoracic surgery market provides an analysis of the key trends expected to impact the market through 2016-2020. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.
The global thoracic surgery market is expected to grow at a CAGR of over 10% during the forecast period. According to Barath Palada, one of the lead analyst at Technavio for cardiovascular devices research, “The thoracic surgery market is anticipated to grow at a rapid pace during the forecast period. The most significant factor contributing to this growth is the rise in the incidence of cardiovascular diseases such as peripheral vascular disease (PVD) and aortic aneurysm. The market is also driven by continuous innovations in treatment methods of cardiovascular diseases.”
The top four emerging trends influencing the global thoracic surgery market according to Technavio healthcare and life sciences research analysts are:
- Growing popularity of robot-assisted cardiac surgery
- Increased use of MRI in cardiac applications
- Use of TAVR technology and self-expandable stents
- Growing use of bio-absorbable stents
Growing popularity of robot-assisted cardiac surgery
Robotic technology allows maneuverability of surgical instruments in closed and complicated spaces inside a human body. Robotic surgical procedures can reduce hospital stays and facilitate cost management. It also ensures improved outcomes, shorter recovery periods, and reduced pain and discomfort.
Awareness of the benefits of robotic surgeries among patients and surgeons has compelled hospitals and clinics to employ robots to perform robot-assisted cardiac surgeries. The benefits of this type of surgery are expected to fuel the growth of the global thoracic surgery market during the forecast period.
Increased use of MRI in cardiac applications
MRI technology enables accurate diagnosis and understanding of injuries, particularly during cardiovascular and neurovascular surgeries. The increased demand for cardiac procedures such as heart valve replacements, stenting, and other electronic cardiac implantations has led to a rise in demand for MRI procedures. MRI scans are increasingly being used to detect tissue damage caused by heart attacks, aneurysms, narrowing of the atria, and heart muscle diseases. It can also be used as an alternative for tests such as computed tomography (CT), X-ray, and angiograms.
The 3D-MRI technique is increasingly being used for better imaging of the heart. The use of magnetic resonance angiography (MRA) is also gaining popularity for monitoring blood flow through the heart. “Thus, the increased use of MRI to monitor heart functions is one of the trends being witnessed in the thoracic surgery market,” says Barath.
Use of TAVR technology and self-expandable stents
A trans-catheter aortic valve (TAVR) has been developed, which is a self-expanding stent that helps in supporting and anchoring the device in the aorta. The benefits of self-expanding stents and advances in TAVR technology will fuel market growth during the forecast period.
Advances in technology, materials, size, and design of heart valves and delivery devices have facilitated surgeons to refine cardiac surgeries, leading to better post-surgical outcomes. For instance, there has been an increase in the use of tissue valves, as these are more biocompatible and durable compared to mechanical prosthetic valves. Vendors are focusing on developing devices that offer valve retrievability and repositioning.
Growing use of bio-absorbable stents
The introduction of new biomaterials for manufacturing of stents, such as bio-absorbable scaffolds and biodegradable polymers are projected to increase the utilization of stents in peripheral interventions. These stents can eliminate the shortcomings of durable polymer stents, thereby encouraging patients to undergo stent implantations.
Companies such as Abbott Vascular are working on bio-absorbable drug-eluting stents, which are expected to revolutionize the market in the future.
Some of the top vendors in the global thoracic surgery market as researched by Technavio analysts are:
- Boston Scientific
- Medtronic
- Sorin
- St. Jude Medical
- Terumo
Browse Related Reports:
- Global Left Atrial Appendage Closure Market 2016-2020
- Global Transcatheter Aortic Valve Replacement Market 2016-2020
- Global LVAD Market 2016-2020
Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact enquiry@technavio.com with your requirements and a link to our subscription platform.
About Technavio
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at media@technavio.com.
